Inflammatory Bowel Disease (IBD) Treatment Market Report

Global and Region Inflammatory Bowel Disease (IBD) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：163
  • REPORT CODE：GMM997011
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Inflammatory Bowel Disease (IBD) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Inflammatory Bowel Disease (IBD) Treatmentmarket, defines the market attractiveness level of Inflammatory Bowel Disease (IBD) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Inflammatory Bowel Disease (IBD) Treatment industry, describes the types of Inflammatory Bowel Disease (IBD) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inflammatory Bowel Disease (IBD) Treatment market and the development prospects and opportunities of Inflammatory Bowel Disease (IBD) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inflammatory Bowel Disease (IBD) Treatment market in Chapter 13.

    By Player:

    • Takeda Pharmaceutical

    • Novartis

    • Biogen Inc

    • Allergan

    • Valeant Pharmaceuticals

    • Pfizer

    • Shire Plc

    • Janssen Biotech Inc (Johnson & Johnson)

    • AbbVie

    By Type:

    • TNF Inhibitors

    • Aminosalicyclates

    • Immunomodulators

    • Corticosteroids

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Inflammatory Bowel Disease (IBD) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Inflammatory Bowel Disease (IBD) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Inflammatory Bowel Disease (IBD) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Inflammatory Bowel Disease (IBD) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Inflammatory Bowel Disease (IBD) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.2 United States Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.4 China Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.5 Japan Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.6 India Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    • 7.7 South Korea Inflammatory Bowel Disease (IBD) Treatment Consumption (2017-2022)

    8 Region and Country-wise Inflammatory Bowel Disease (IBD) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast (2022-2028)

    9 Global Inflammatory Bowel Disease (IBD) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Aminosalicyclates Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunomodulators Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • 9.2 Global Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Global Inflammatory Bowel Disease (IBD) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Aminosalicyclates Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    11 Global Inflammatory Bowel Disease (IBD) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Inflammatory Bowel Disease (IBD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Inflammatory Bowel Disease (IBD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Inflammatory Bowel Disease (IBD) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Inflammatory Bowel Disease (IBD) Treatment Market Competitive Analysis

    • 14.1 Takeda Pharmaceutical

      • 14.1.1 Takeda Pharmaceutical Company Details

      • 14.1.2 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.2 Novartis

      • 14.2.1 Novartis Company Details

      • 14.2.2 Novartis Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.3 Biogen Inc

      • 14.3.1 Biogen Inc Company Details

      • 14.3.2 Biogen Inc Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biogen Inc Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.4 Allergan

      • 14.4.1 Allergan Company Details

      • 14.4.2 Allergan Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.5 Valeant Pharmaceuticals

      • 14.5.1 Valeant Pharmaceuticals Company Details

      • 14.5.2 Valeant Pharmaceuticals Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Valeant Pharmaceuticals Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.7 Shire Plc

      • 14.7.1 Shire Plc Company Details

      • 14.7.2 Shire Plc Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Shire Plc Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.8 Janssen Biotech Inc (Johnson & Johnson)

      • 14.8.1 Janssen Biotech Inc (Johnson & Johnson) Company Details

      • 14.8.2 Janssen Biotech Inc (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Janssen Biotech Inc (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • 14.9 AbbVie

      • 14.9.1 AbbVie Company Details

      • 14.9.2 AbbVie Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Inflammatory Bowel Disease (IBD) Treatment

    • Figure Inflammatory Bowel Disease (IBD) Treatment Picture

    • Table Global Inflammatory Bowel Disease (IBD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inflammatory Bowel Disease (IBD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Inflammatory Bowel Disease (IBD) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Inflammatory Bowel Disease (IBD) Treatment Consumption by Country (2017-2022)

    • Figure United States Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Inflammatory Bowel Disease (IBD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Inflammatory Bowel Disease (IBD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Aminosalicyclates Consumption and Growth Rate (2017-2022)

    • Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aminosalicyclates Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Inflammatory Bowel Disease (IBD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Inflammatory Bowel Disease (IBD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Biogen Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen Inc Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Inc Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Shire Plc (Foundation Year, Company Profile and etc.)

    • Table Shire Plc Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Plc Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table Janssen Biotech Inc (Johnson & Johnson) (Foundation Year, Company Profile and etc.)

    • Table Janssen Biotech Inc (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Biotech Inc (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inflammatory Bowel Disease (IBD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inflammatory Bowel Disease (IBD) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US